iCAD Announces Promising Clinical Data to be Presented on Treatment of Early-Stage Breast and Gynecological Cancers at ESTRO 2020 Online Congress

NEXT STORY
Real-World Evidence (RWE) Solutions Market Worth $3.13 billion by 2027- Exclusive Report Covering Pre and Post COVID-19 Market Analysis by Meticulous Research®
PREV STORY
BioNTech and InstaDeep Announce Strategic Collaboration and Form AI Innovation Lab to Develop Novel Immunotherapies
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Data From TOPACIO Trial Reported at SGO Demonstrates Compelling Clinical Activity of ZEJULA in Combination With an Anti-PD-1 Antibody in Patients With Platinum Resistant/Refractory Ovarian Cancer

Efficacy of niraparib in combination with an anti-PD-1 mAb surpasses historical efficacy benchmarks for ...

author_avatar
NASDAQ Market News

Conférence de presse de mardi de la conférence mondiale sur le cancer du poumon : Améliorer le taux de guérison du cancer du poumon de stade III

TORONTO, 26 sept. 2018 (GLOBE NEWSWIRE) -- La conférence d'aujourd'hui de la 19e conférence mondiale ...

author_avatar
NASDAQ Market News

Integra LifeSciences Announces First Patient Enrolled in Cadence® Total Ankle System Post-Market Study

PLAINSBORO, N.J., Sept. 21, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a ...

author_avatar
NASDAQ Market News